Soligenix (SNGX) Common Equity (2010 - 2026)
Soligenix (SNGX) reported Common Equity of $6.65 million for Q2 2026, up 263.4% from $1.83 million a year earlier and up 115.1% from the prior quarter.
Powered by 
Analysis
Soligenix (SNGX) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Soligenix posted Common Equity of $5.29 million, up 28.5% from FY2024.
- Common Equity has a five-year compound annual growth rate of 7.2% (FY2020 to FY2025).
- By year, Common Equity came in at $4.12 million in FY2024 (+63.3%), $2.52 million in FY2023, -$2.47 million in FY2022 and $10.72 million in FY2021 (+186.6%).
- Five-year quarterly Common Equity spans a low of -$3.39 million in Q1 2023 and a high of $15.05 million in Q3 2021.
- Year over year, Common Equity gained in six of the last eight quarters, with growth averaging 95.4%.
- The high point for year-over-year Common Equity in five years was Q1 2025 (growth of 407.3%); the low point was Q3 2022 (a decline of 93.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.09 million (Q1 2026), $5.29 million (Q4 2025) and $7.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Soligenix | 6.06 Mn | 6.06 Mn | - | 6.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.65 Mn |
| Mar 31, 2026 | 3.09 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 7.60 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 5.94 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 768,372.00 |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 5.80 Mn |
| Mar 31, 2023 | -3.39 Mn |
| Dec 31, 2022 | -2.47 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 6.58 Mn |
| Dec 31, 2021 | 10.72 Mn |
| Sep 30, 2021 | 15.05 Mn |
API Access
Soligenix Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SNGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SNGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SNGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();